Results 151 to 160 of about 42,114 (261)

Cerebral Blood and Cerebrospinal Fluid Flow Dynamics in Endurance Athletes: Associations With Aortic Recoil and Heart Rate

Scandinavian Journal of Medicine &Science in Sports, Volume 36, Issue 3, March 2026.
ABSTRACT Endurance training elicits profound cardiovascular adaptations, including lower heart rate (HR), greater stroke volume (SV), and enhanced aortic Windkessel function. This study aimed to investigate cerebral blood and cerebrospinal fluid (CSF) flow dynamics in endurance athletes and their relations with cardiovascular parameters.
Daisuke Hoshi, Marina Fukuie, Tsubasa Tomoto, David C. Zhu, Rong Zhang, Keigo Ohyama‐Byun, Seiji Maeda, Jun Sugawara, Takashi Tarumi   +8 more
wiley   +1 more source

Suppression of premature ventricular complexes with the PDE5 inhibitor sildenafil: First clinical experience

Experimental Physiology, Volume 111, Issue 3, Page 625-631, 1 March 2026.
Abstract The phosphodiesterase‐5 inhibitor sildenafil suppresses ventricular arrhythmias in a sheep model of drug‐induced long QT. In that study, ventricular arrhythmias were abolished by reducing premature ventricular complexes (PVCs) and delaying PVC onset, thus preventing ‘R‐on‐T’ ventricular tachycardia.
David C. Hutchings, Christopher P. Denton, Luigi Venetucci, Andrew W. Trafford   +3 more
wiley   +1 more source

Remdesivir-Induced Extreme Sinus Bradycardia in COVID-19. [PDF]

Cureus, 2022
Wasef N, Hamilton S, Fatima T, Osgood E.
europepmc   +2 more sources

Complicated appendicitis, acute pancreatitis, pleural effusion, and sinus bradycardia in a COVID-19 patient. [PDF]

Clin Case Rep, 2023
Hatami D, Alavi SMA.
europepmc   +1 more source

Cardiac‐specific Kv1.1 deficiency alters cardiomyocyte electrophysiology without modifying overall cardiac function or arrhythmia susceptibility

Experimental Physiology, Volume 111, Issue 3, Page 1120-1133, 1 March 2026.
Abstract The leading cause of epilepsy‐related mortality is sudden unexpected death in epilepsy (SUDEP), resulting from seizure‐induced cardiorespiratory arrest by mechanisms that remain unresolved. Mutations in ion channel genes expressed in both brain and heart represent SUDEP risk factors because they can disrupt neural and cardiac rhythms ...
Kelsey Halvorson, Man Si, Krystle Trosclair, Ellen Aughenbaugh, Maxine Parkinson, Nicole M. Gautier‐Hall, Megan Watts, Frederica Kizek, Md. Shenuarin Bhuiyan, Paari Dominic, Kathryn A. Hamilton, Edward Glasscock   +11 more
wiley   +1 more source

Marked Sinus Bradycardia in a COVID-19 Patient. [PDF]

Case Rep Cardiol
Valladares C, Kaplan A.
europepmc   +1 more source

Durvalumab-Associated Myocarditis Initially Presenting With Sinus Bradycardia Progressing Into Complete Heart Block. [PDF]

Cureus, 2023
Bae S, Vaysblat M, Ng J, Beccarino N, Makaryus J, Sarkar K.   +5 more
europepmc   +1 more source

Sinus Bradycardia, CTCAE [PDF]

, 2020
openaire   +1 more source

Targetable Effects of the Anesthetic, Ubiquinone‐5, on Murine Cardiac Rhythm

The FASEB Journal, Volume 40, Issue 4, 28 February 2026.
The novel anesthetic, ubiquinone‐5 (Ub5), causes second‐degree heart block, in part, by compromising the mitochondrial membrane potential (ΔΨ) in cardiomyocytes. Ub5‐mediated inhibition of electron transport and induction of excessive proton leak via the aspartate–glutamate carrier, Aralar, prevent mitochondria from generating and maintaining an ...
Haeun Lim, Rong Lu, Chloe Shi, Richard J. Levy   +3 more
wiley   +1 more source

Carfilzomib-induced sinus bradycardia: A case report and literature review. [PDF]

SAGE Open Med Case Rep
Zhao X, Sun D, Xu R, Qiu Y, Zhao S, Guo C, Chang C, Zhang J.   +7 more
europepmc   +1 more source